Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT with PFLL and Toripalimab in Oligometastatic NPC
NCT06486220Phase 3Not yet recruiting
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in nasopharyngeal carcinoma (NPC). Planned start Jul 2024; status: not yet recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT06486220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06486220.